The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity-Reference-Cited by-同舟云学术

The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity

Published:2023-07 Issue:7 Volume:41 Page:1207-1221.e12
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Ho Patricia,Melms Johannes C.,Rogava Meri,Frangieh Chris J.,Poźniak Joanna,Shah Shivem B.,Walsh Zachary,Kyrysyuk Oleksandr,Amin Amit Dipak,Caprio Lindsay,Fullerton Benjamin T.,Soni Rajesh Kumar,Ager Casey R.,Biermann Jana,Wang Yiping,Khosravi-Maharlooei Mohsen,Zanetti Giorgia,Mu Michael,Fatima Hijab,Moore Emily K.,Vasan Neil,Bakhoum Samuel F.,Reiner Steven L.,Bernatchez Chantale,Sykes Megan,Mace Emily M.,Wucherpfennig Kai W.,Schadendorf Dirk,Bechter Oliver,Shah Parin,Schwartz Gary K.,Marine Jean-Christophe,Izar Benjamin^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference67 articles.

1. Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001;Hamid;Ann. Oncol.,2019

2. Five-Year survival with combined nivolumab and ipilimumab in advanced melanoma;Larkin;N. Engl. J. Med.,2019

3. Loss of IFN-gamma pathway genes in tumor cells as a mechanism of resistance to anti-CTLA-4 therapy;Gao;Cell,2016

4. Mutations associated with acquired resistance to PD-1 blockade in melanoma;Zaretsky;N. Engl. J. Med.,2016

5. Resistance to checkpoint blockade therapy through inactivation of antigen presentation;Sade-Feldman;Nat. Commun.,2017

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic Characterization of Primary Mediastinal B-Cell Lymphoma: Pathogenesis and Patient Outcomes;Journal of Clinical Oncology;2024-02-01

2. CMTM6 promotes hepatocellular carcinoma progression through stabilizing β-catenin;Cancer Letters;2024-02

3. Transmembrane Protein CMTM6 Alleviates Ocular Inflammatory Response and Improves Corneal Epithelial Barrier Function in Experimental Dry Eye;Investigative Opthalmology & Visual Science;2024-01-02

4. Improving cancer immunotherapy by preventing cancer stem cell and immune cell linking in the tumor microenvironment;Biomedicine & Pharmacotherapy;2024-01

5. Massively parallel base editing screens to map variant effects on anti-tumor hallmarks of primary human T cells;2023-12-14